Bhanu Singh, BVSc, MS, DACVP, DABT, Fellow IATP

Senior Director, Nonclinical Safety
Gilead Sciences, California, United States

Dr Bhanu Singh is Senior Director, Pathology at Gilead Sciences, He leads the pathology support of nonclinical safety studies for virology portfolio. He also serves as the lead toxicologist for long-acting injectable programs and as subject matter expert on internally at Gilead and External working groups for issues related to the development of long-acting injectable programs. Dr Bhanu Singh is a board-certified veterinary anatomic pathologist (DACVP) and toxicologist (DABT) and is also a Fellow of International Academy of Toxicologic Pathology (IATP).

Disclosure information not submitted.

Presentation(s):

• Industry Roundtable: Industry Advances in the Advancement of Long-Acting Therapies - Round Table Discussion with Gilead Sciences

  Thursday, July 17, 2025
  1:00 PM - 2:30 PM EDT